Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DL-Homocysteine thiolactone hydrochloride (DL-Homocysteinethiolactone hydrochloride) 是具有根生长抑制特性的环状氨基酸衍生物。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 g | ¥ 163 | 现货 | ||
10 g | ¥ 226 | 现货 |
产品描述 | DL-Homocysteine thiolactone hydrochloride (DL-Homocysteinethiolactone hydrochloride) is a cysteine derivative that binds to and induces conformational changes in various plasma proteins, slowing coagulation and inducing oxidative stress. It decreases left ventricular systolic blood pressure and cardiac force and induces seizures in vivo. |
体外活性 | Acuted administration of DL-Homocysteinethiolactone hydrochloride (DL-Hcy TLHC) induces significant reduction of CF and partly of heart contractility, which confirms its cardiodepressive effect.?The simultaneous application of different inhibitors of important cardiovascular gasotransmitters with DL-Hcy TLHC shows that additional HO-1 inhibition induces more powerful effects than NOS or CSE inhibition.?The inhibition of CO production significantly increases DL-Hcy TLHC-induced effects on cardiodynamic parameters, while NOS and CSE inhibition only affects CF. Acuted administration of DL-Hcy TLHC and different gasotransmitter inhibitors does not show prooxidant potential[1]. |
细胞实验 | Only groups of hearts in which the CPP/CF relationship was studied twice in the absence of drugs were included in the study. After perfusion in the absence of any medication (control conditions), hearts were perfused with: 10?μM DL-Homocysteinethiolactone hydrochloride (DL-Hcy TLHC); 10?μM DL-Hcy TLHC + 30?μM L-NAME (N ω-Nitro-L-arginine methyl ester, an inhibitor of NOS); 10?μM DL-Hcy TLHC + 10?μM DL-PAG (DL-Propargylglycine, an inhibitor of cystathionine gamma lyase-CSE); 10?μM DL-Hcy TLHC + 10?μM ZnPPR IX (protoporphyrin IX zinc, an inhibitor of HO-1) and compared to the respective controls[1]. |
别名 | DL-Homocysteinethiolactone hydrochloride, DL-高半胱氨酸硫内酯盐酸盐 |
分子量 | 153.63 |
分子式 | C4H8ClNOS |
CAS No. | 6038-19-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (162.74 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 6.5091 mL | 32.5457 mL | 65.0915 mL | 162.7286 mL |
5 mM | 1.3018 mL | 6.5091 mL | 13.0183 mL | 32.5457 mL | |
10 mM | 0.6509 mL | 3.2546 mL | 6.5091 mL | 16.2729 mL | |
20 mM | 0.3255 mL | 1.6273 mL | 3.2546 mL | 8.1364 mL | |
50 mM | 0.1302 mL | 0.6509 mL | 1.3018 mL | 3.2546 mL | |
100 mM | 0.0651 mL | 0.3255 mL | 0.6509 mL | 1.6273 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
DL-Homocysteine thiolactone hydrochloride 6038-19-3 Metabolism Endogenous Metabolite inhibit DL-Homocysteinethiolactone hydrochloride DL-Homocysteine thiolactone Inhibitor DL-Homocysteine thiolactone Hydrochloride DL Homocysteine thiolactone hydrochloride DLHomocysteine thiolactone hydrochloride DL-Homocysteinethiolactone Hydrochloride DL-高半胱氨酸硫内酯盐酸盐 inhibitor